Want to see JP:7975 full AI Analyst Report?
Top Page
LIHIT LAB., INC.
(7975)
Select Model
Select Model
Rating:51Neutral
Price Target:
¥1,109.00
▼(-11.07% Downside)
Action:Reiterated
Date:08/06/26
The score is held back primarily by volatile profitability and especially weak/negative free cash flow in multiple years (with a large deficit in 2026), despite a conservatively positioned balance sheet. Technicals are neutral with only modest momentum, and valuation looks somewhat rich (P/E ~28.5) with only moderate dividend support (~2.23%).
Positive Factors
Conservative balance sheet
A conservatively positioned balance sheet with modest debt and a sizable equity cushion provides durable financial resilience. Manageable leverage and a ¥10B+ equity base reduce insolvency risk, preserve strategic flexibility, and allow the company to absorb demand shocks or fund selective investments over months.
Negative Factors
Negative and volatile free cash flow
Repeated negative free cash flow, culminating in a large 2026 deficit, weakens internal funding and financial flexibility. Poor cash conversion restricts the firm's ability to self-fund capex, dividends or acquisitions, heightening reliance on external financing and increasing medium-term liquidity risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
A conservatively positioned balance sheet with modest debt and a sizable equity cushion provides durable financial resilience. Manageable leverage and a ¥10B+ equity base reduce insolvency risk, preserve strategic flexibility, and allow the company to absorb demand shocks or fund selective investments over months.
Read all positive factors
LIHIT LAB., INC. (7975) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥3.80B
Dividend Yield2.23%
Average Volume (3M)833.00
Price to Earnings (P/E)28.5
Beta (1Y)0.14
Revenue Growth-1.38%
EPS Growth-64.66%
CountryJP
Employees591
SectorGeneral
Sector StrengthN/A
IndustryBusiness Equipment & Supplies
Share Statistics
EPS (TTM)39.32
Shares Outstanding3,815,700
10 Day Avg. Volume1,000
30 Day Avg. Volume833
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)0.38
Price to Sales (P/S)0.46
P/FCF Ratio-3.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LIHIT LAB., INC. Business Overview & Revenue Model
Company Description
Lihit Lab., Inc., founded in Osaka, Japan, in 1938, manufactures and distributes a comprehensive range of office supplies both domestically and internationally. Their extensive product portfolio includes an array of filing and organizational solut...
How the Company Makes Money
The company primarily makes money by selling its stationery and office-supply products to business-to-business and consumer channels. Key revenue streams are product sales from (1) filing and document management goods (binders, folders, files, cas...
LIHIT LAB., INC. Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
74
Positive
Cash Flow
33
Negative
| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.20B | 9.12B | 9.22B | 8.80B | 8.51B | 8.69B |
| Gross Profit | 3.11B | 3.00B | 2.88B | 2.52B | 2.50B | 2.90B |
| EBITDA | 467.78M | 306.06M | 822.07M | 174.54M | 261.38M | 725.53M |
| Net Income | 133.41M | 67.07M | 411.57M | -93.73M | -24.41M | 262.51M |
Balance Sheet | ||||||
| Total Assets | 13.68B | 13.52B | 13.43B | 13.12B | 13.03B | 13.62B |
| Cash, Cash Equivalents and Short-Term Investments | 1.19B | 728.51M | 2.33B | 1.24B | 1.08B | 2.26B |
| Total Debt | 254.00M | 282.00M | 437.50M | 751.50M | 445.00M | 698.00M |
| Total Liabilities | 2.64B | 2.54B | 2.79B | 2.88B | 2.81B | 3.51B |
| Stockholders Equity | 11.04B | 10.98B | 10.64B | 10.24B | 10.22B | 10.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.36B | 17.92M | -196.64M | -825.63M | 608.64M |
| Operating Cash Flow | 0.00 | 47.73M | 290.49M | 663.33M | -745.70M | 720.74M |
| Investing Cash Flow | 0.00 | -1.40B | 1.18B | -726.91M | -112.96M | -127.15M |
| Financing Cash Flow | 0.00 | -241.69M | -400.05M | 220.14M | -339.35M | -139.16M |
LIHIT LAB., INC. Technical Analysis
Negative
1247.00
Price Trends
1089.26
Positive
1130.56
Negative
1174.45
Negative
Market Momentum
4.03
Positive
49.45
Neutral
31.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7975, the sentiment is Negative. The current price of 1247 is above the 20-day moving average (MA) of 1107.40, above the 50-day MA of 1089.26, and above the 200-day MA of 1174.45, indicating a neutral trend. The MACD of 4.03 indicates Positive momentum. The RSI at 49.45 is Neutral, neither overbought nor oversold. The STOCH value of 31.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7975.
LIHIT LAB., INC. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥390.40B | 17.50 | 8.43% | 2.95% | 9.28% | 17.72% | |
77 Outperform | ¥143.54B | 20.16 | ― | 2.09% | 5.24% | -2.53% | |
76 Outperform | ¥218.24B | 15.86 | ― | 2.56% | 1.83% | -7.02% | |
65 Neutral | ¥40.34B | 23.97 | ― | 1.77% | 2.05% | -15.62% | |
59 Neutral | ¥22.58B | 22.31 | ― | 1.88% | -1.27% | 135.35% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | ¥3.80B | 28.48 | ― | 2.03% | -1.38% | -64.66% |
* General Sector Average
JP:7975
LIHIT LAB., INC.
1,108.00
-14.77
-1.32%
JP:7984
Kokuyo Co
873.90
-29.94
-3.31%
JP:4218
Nichiban Co., Ltd.
1,962.00
-9.19
-0.47%
JP:7846
Pilot Corporation
1,813.50
392.25
27.60%
JP:7962
King Jim Co., Ltd.
805.00
-27.74
-3.33%
JP:7976
Mitsubishi Pencil Company, Limited
2,846.00
856.34
43.04%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.